GlassScriptPhysician profile
Diane M Mrava
NPI 1346250925
$3,330.94
in general payments reported to CMS, 2019-2025
26 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $242 · 2021: $447 · 2022: $607 · 2023: $411 · 2024: $618 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $808.11 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $306.56 | 2021-2024 | |
| Astellas Pharma US INC | $261.91 | 2022-2025 | Veozah |
| Organon LLC | $242.11 | 2021-2024 | Nexplanon |
| Hologic Sales and Service, LLC | $199.83 | 2019-2024 | Aptima, Novasure, Acessa Provu System |
| Sumitomo Pharma America, INC. | $163.44 | 2023 | Myfembree |
| Exeltis, USA INC. | $158.40 | 2019-2023 | Slynd |
| Myovant Sciences INC. | $135.09 | 2022 | |
| Therapeuticsmd, INC. | $129.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.90 | 2019-2024 | |
| Pacira Pharmaceuticals Incorporated | $110.62 | 2019 | |
| Pfizer INC. | $105.11 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $75.22 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $74.36 | 2019-2021 | |
| Optumhealth Care Solutions, LLC | $73.73 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $67.59 | 2019 | |
| Medical Device Business Services, INC. | $67.54 | 2024 | Harmonic |
| Agile Therapeutics, INC. | $54.02 | 2021 | |
| Minerva Surgical, INC | $30.51 | 2022 | |
| Meditrina | $29.61 | 2024 | |
| Lupin INC. | $28.01 | 2019-2020 | |
| Covidien LP | $25.59 | 2019 | |
| Allergan, INC. | $22.95 | 2019 | |
| Renovia INC | $15.85 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.36 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Mrava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.